Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer

Clinical trial NCT02064829 · COMPLETED

Trial details

NCT number: NCT02064829
Sponsor: Sorrento Therapeutics, Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Metastatic Breast Cancer Locally Recurrent Breast Cancer

Start date: 2014-03-01
Primary completion: 2015-02-01
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.